|
Volumn 3, Issue 3, 2011, Pages 284-291
|
Synthesis and characterization of IMPY derivatives that regulate metal-induced amyloid-β aggregation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALZHEIMER'S DISEASE;
BIFUNCTIONAL;
DESIGN STRATEGIES;
DISAGGREGATION;
HIGH RESOLUTION;
IN-VITRO;
METAL CHELATION;
METAL-FREE CONDITIONS;
NEURODEGENERATION;
SMALL MOLECULES;
STRUCTURE-BASED;
GLYCOPROTEINS;
METAL IONS;
NEURODEGENERATIVE DISEASES;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
METALS;
6 (6 IODOIMIDAZO[1,2 A]PYRIDIN 2 YL) N,N DIMETHYLPYRIDIN 3 AMINE;
6 (IMIDAZO[1,2 A]PYRIDIN 2 YL) N,N DIMETHYLPYRIDIN 3 AMINE;
AMYLOID BETA PROTEIN;
IMIDAZO[1,2 A]PYRIDINE DERIVATIVE;
METAL;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
ARTICLE;
CHELATION THERAPY;
DEGENERATIVE DISEASE;
DRUG DESIGN;
DRUG MECHANISM;
DRUG STRUCTURE;
DRUG SYNTHESIS;
METAL BINDING;
NEUROPATHOLOGY;
PRIORITY JOURNAL;
PROTEIN AGGREGATION;
PROTEIN INTERACTION;
ALZHEIMER DISEASE;
AMYLOID BETA-PEPTIDES;
CHELATING AGENTS;
DRUG DESIGN;
HUMANS;
METALS;
PYRAZOLES;
PYRIDINES;
|
EID: 79952522223
PISSN: 17565901
EISSN: 1756591X
Source Type: Journal
DOI: 10.1039/c0mt00077a Document Type: Article |
Times cited : (38)
|
References (46)
|